Immunological Basis for the Development of Allergic Diseases-Prevalence, Diagnosis and Treatment Strategies

S. N. Pramod
{"title":"Immunological Basis for the Development of Allergic Diseases-Prevalence, Diagnosis and Treatment Strategies","authors":"S. N. Pramod","doi":"10.5772/INTECHOPEN.95804","DOIUrl":null,"url":null,"abstract":"Allergy is an immune disorder due to over responsiveness of immune system to a relatively normal and harmless antigen; derived from environmental and dietary substances commonly referred as allergens. Allergy is an IgE mediated type I hypersensitivity which is characterized by the degranulation of specialized white blood cells known as mast cells and basophils. Majority of characterized allergens are proteinaceous in nature and induce Th2 response. Specific Th2 cytokines elicit the induction of allergen specific IgE antibodies in sensitive individuals. The IgE binds to Fc epsilon receptor on basophil/mast cells and on exposure, allergens cross links the IgE and induce release of hypersensitivity mediators that result in allergic symptoms. The symptoms varies from mild allergies like hay fever, itchiness, rashes, rhinatisis, conjunctivitis to a severe condition such as Asthma and some time life threatening anaphylaxis. At present a various blood based test exist to diagnose allergies which include skin prick, patch test and Specific IgE tests. The best treatment available is to avoid exposure to allergens alternatively use of anti-histamines, steroids or other symptom reducing medications are in practice. Immunotherapy to desensitize the response to allergen and targeted therapy are promising for allergy in future.","PeriodicalId":147231,"journal":{"name":"Cell Interaction - Molecular and Immunological Basis for Disease Management","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Interaction - Molecular and Immunological Basis for Disease Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/INTECHOPEN.95804","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Allergy is an immune disorder due to over responsiveness of immune system to a relatively normal and harmless antigen; derived from environmental and dietary substances commonly referred as allergens. Allergy is an IgE mediated type I hypersensitivity which is characterized by the degranulation of specialized white blood cells known as mast cells and basophils. Majority of characterized allergens are proteinaceous in nature and induce Th2 response. Specific Th2 cytokines elicit the induction of allergen specific IgE antibodies in sensitive individuals. The IgE binds to Fc epsilon receptor on basophil/mast cells and on exposure, allergens cross links the IgE and induce release of hypersensitivity mediators that result in allergic symptoms. The symptoms varies from mild allergies like hay fever, itchiness, rashes, rhinatisis, conjunctivitis to a severe condition such as Asthma and some time life threatening anaphylaxis. At present a various blood based test exist to diagnose allergies which include skin prick, patch test and Specific IgE tests. The best treatment available is to avoid exposure to allergens alternatively use of anti-histamines, steroids or other symptom reducing medications are in practice. Immunotherapy to desensitize the response to allergen and targeted therapy are promising for allergy in future.
过敏性疾病发展的免疫学基础——患病率、诊断和治疗策略
过敏是由于免疫系统对相对正常和无害的抗原反应过度而引起的一种免疫紊乱;来源于环境和饮食物质,通常被称为过敏原。过敏是一种IgE介导的I型超敏反应,其特征是肥大细胞和嗜碱性粒细胞等特化白细胞的脱颗粒。大多数特征过敏原本质上是蛋白性的,并诱导Th2反应。特异性Th2细胞因子可诱导敏感个体产生过敏原特异性IgE抗体。IgE与嗜碱性粒细胞/肥大细胞上的Fc epsilon受体结合,暴露时,过敏原与IgE交联并诱导超敏介质的释放,从而导致过敏症状。症状从轻微的过敏如花粉热、瘙痒、皮疹、鼻炎、结膜炎到严重的过敏如哮喘和有时危及生命的过敏反应不等。目前诊断过敏症的血检方法有皮肤点刺试验、斑贴试验和特异性IgE试验。最好的治疗方法是避免接触过敏原,或者使用抗组胺药、类固醇或其他减轻症状的药物。免疫脱敏治疗和靶向治疗是治疗过敏原的重要手段。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信